# Progress Note 06 — Focused Visit (Follow-up)

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Frederick Cook (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-EX006-SYN-TD
- Date: 1930-09-29
- Fictional facility: St. Posthumous Health Center
- Fictional author: Harriet Okafor-Brandt, MD
- Calendar frame: true historical dates (modern content is anachronistic)

> True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

- Visit type: Focused Visit (Follow-up)

## Chief complaint

Twelve-week review of blood pressure and lipids three weeks after a gout flare on hydrochlorothiazide. **S**

## History of present illness

Mr. Cook returns three weeks after the same-day visit for gout of his right big toe. The pain settled within four days of colchicine, he took the last tablet five days after starting, and he had no diarrhea or muscle aches. He has had no further attacks. He continues hydrochlorothiazide, amlodipine, atorvastatin and aspirin without missed doses. His home readings average 132/80. He has had no stroke symptoms. His Social Security retirement benefits and Medicare have been approved, and he has signed a six-month lease on his room. He is writing most mornings and says he feels steadier. **S**

| Element | Detail |
|---|---|
| Gout | Settled within four days on colchicine; no further attacks |
| Home blood pressure | Average 132/80 |
| Medicine effects | No diarrhea, muscle aches or bleeding |
| Social | Benefits and Medicare approved; six-month lease |

## Review of systems

| System | Result | Finding |
|---|---|---|
| Musculoskeletal | Negative | Right big toe back to normal; no other joint pain; no muscle aches |
| Cardiovascular | Negative | No chest pain or ankle swelling |
| Neurological | Negative | No weakness, numbness, speech trouble, or loss of vision |
| Psychiatric | Negative | Mood steadier; no thoughts of self-harm |

4 systems reviewed. **S**

## Current medications

- Amlodipine 5 mg tablet, one tablet by mouth daily **S**
- Atorvastatin 40 mg tablet, one tablet by mouth daily **S**
- Aspirin 81 mg delayed-release tablet, one tablet by mouth daily **S**
- Losartan 50 mg tablet, one tablet by mouth daily **S**

## Allergies

- No known allergy **S**

## Objective

BP 134/80 mmHg; pulse 68 bpm; respirations 14/min; temperature 36.5 °C; oxygen saturation 97% on room air; weight 75 kg; BMI 24.5 kg/m². All vital signs are synthetic.

Uric acid: 8.4 mg/dL (high); Sodium: 137 mmol/L; Potassium: 3.7 mmol/L; Creatinine: 1.04 mg/dL; eGFR: 80 mL/min/1.73 m²; Total cholesterol: 142 mg/dL; HDL cholesterol: 48 mg/dL; LDL cholesterol: 68 mg/dL; Triglycerides: 130 mg/dL; ALT: 26 U/L. All results are synthetic.

## Change since baseline

- Sodium: 140 mmol/L at baseline, 137 mmol/L at this visit **S**
- Potassium: 4.2 mmol/L at baseline, 3.7 mmol/L at this visit **S**
- Creatinine: 0.98 mg/dL at baseline, 1.04 mg/dL at this visit **S**
- eGFR: 86 mL/min/1.73 m² at baseline, 80 mL/min/1.73 m² at this visit **S**
- Total cholesterol: 228 mg/dL (high) at baseline, 142 mg/dL at this visit **S**
- HDL cholesterol: 46 mg/dL at baseline, 48 mg/dL at this visit **S**
- LDL cholesterol: 148 mg/dL (high) at baseline, 68 mg/dL at this visit **S**
- Triglycerides: 170 mg/dL (high) at baseline, 130 mg/dL at this visit **S**
- ALT: 22 U/L at baseline, 26 U/L at this visit **S**

## Immunizations given today

- Hepatitis B vaccine, CpG-adjuvanted (two-dose series), dose 2 of 2 **S**

## Physical examination

| System | Finding |
|---|---|
| General | Well; blood pressure 134/80, pulse 68, weight 75.0 kg |
| Right foot | First metatarsophalangeal joint normal, no swelling or tenderness; no tophi |
| Neck | Soft right carotid bruit, unchanged |

All examination findings are synthetic. **S**

## Assessment and plan

1. **Drug-induced gout, first flare, resolved** (M10.271). Serum urate 8.4 mg/dL three weeks after the flare, on hydrochlorothiazide. The 1924 ACR guideline advises switching hydrochlorothiazide to another blood pressure drug when feasible, and losartan, which lowers urate, is a good choice. After a single flare, without kidney disease, tophi, kidney stones or a urate above 9 mg/dL, urate-lowering drugs are not started. **S**
   - Stop hydrochlorothiazide.
   - No urate-lowering drug now; reconsider if flares recur.
   - Fewer sugary drinks and less red meat and shellfish; no alcohol.
2. **Essential hypertension, not yet at target** (I10). Office 134/80 and home 132/80, still above 130/80. Sodium 137, potassium 3.7 mmol/L, creatinine 1.04 mg/dL, eGFR 80, the baseline before a renin-angiotensin drug. **S**
   - Losartan 50 mg daily in place of hydrochlorothiazide; continue amlodipine 5 mg.
   - Potassium and creatinine one to two weeks after starting losartan.
   - Review in four weeks.
3. **Asymptomatic right internal carotid stenosis** (I65.21). LDL 68 mg/dL from 148, a 54 percent reduction, ten weeks after starting atorvastatin 40 mg; total cholesterol 142, HDL 48, triglycerides 130 mg/dL; ALT 26 U/L. No symptoms. **S**
   - Continue atorvastatin 40 mg and aspirin 81 mg.
   - Repeat lipid panel in 6 to 12 months.
   - Repeat duplex in about ten months.
4. **Re-entry after incarceration** (Z65.2). Housing and income are now settled; mood steadier. **S**
   - Second hepatitis B vaccine dose today.
   - Repeat PHQ-9 at the next visit.

## Protocol monitoring

Items the monitoring protocol calls for at this visit. **S**

| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Examination | Office blood pressure, seated, average of two readings | Every visit | Completed today | 134/80 mmHg |
| Self-management | Home blood pressure monitoring | At diagnosis and after each treatment change | Completed today | Average 132/80; repeat after the switch to losartan |
| Laboratory | Sodium, potassium, creatinine and eGFR | Baseline; early after starting a diuretic or an ARB; then every 6 months | Completed today | Sodium 137, potassium 3.7 mmol/L, creatinine 1.04 mg/dL, eGFR 80; baseline before losartan; repeat ordered for one to two weeks after starting |
| Laboratory | Lipid panel | Baseline; 4 to 12 weeks after starting a statin; then every 3 to 12 months | Completed today | Total cholesterol 142, HDL 48, LDL 68, triglycerides 130 mg/dL, ten weeks after starting atorvastatin; LDL down 54 percent |
| Laboratory | ALT on a statin | Baseline, then with the first lipid check or with symptoms | Completed today | 26 U/L |
| Laboratory | Serum urate after a gout flare | Two to four weeks after the flare settles, and on any change in therapy | Completed today | 8.4 mg/dL on hydrochlorothiazide |
| Medication safety | Review of drugs that raise urate | After a gout flare | Completed today | Hydrochlorothiazide stopped; losartan started; low-dose aspirin continued because its benefit outweighs its small effect on urate |
| Medication safety | Urate-lowering therapy | After each flare | Not indicated | Single flare; no kidney disease, tophi, stones, or urate above 9 mg/dL |
| Medication safety | Antiplatelet adherence and bleeding | Every visit | Completed today | No bleeding |
| Medication safety | Statin adherence and muscle symptoms | Every visit | Completed today | No muscle symptoms, including during colchicine |
| Imaging | Carotid duplex ultrasound for known 50 percent or greater stenosis on medical therapy | At diagnosis, then yearly | Up to date | Next duplex due in about ten months |
| Self-management | Stroke warning signs (BE FAST) and calling 911 | Every visit | Completed today | No symptoms |
| Survey | Depression screen (PHQ-9) | Annually | Up to date | PHQ-9 7 at intake; mood steadier by interview; repeat planned at the next visit |
| Self-management | Re-entry social needs: housing, income, benefits, records | Every visit until settled | Completed today | Social Security and Medicare approved; six-month lease |

## Goal progress

- Office and home blood pressure below 130/80 mmHg by four months. In progress; target 1930-10-27. **S**
- LDL cholesterol lowered by at least half on a statin. Outcome by 1930-09-29: LDL 68 mg/dL, from 148 mg/dL, on atorvastatin 40 mg. **S**
- Knows the warning signs of stroke and to call 911 at once. Outcome by 1930-07-21: Taught and repeated back the BE FAST signs at the consultation visit. **S**
- A stable room, Social Security and Medicare in place, and a health insurance card in hand. Outcome by 1930-09-29: Six-month lease on his room; retirement benefits and Medicare approved. **S**

## Medication changes

- Stopped: Hydrochlorothiazide 25 mg tablet, one tablet by mouth each morning **S**
- Started: Losartan 50 mg tablet, one tablet by mouth daily **S**

## Guideline basis

- 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults (Jones DW, et al. Hypertension 2025;82:e212-e316) (2025), American Heart Association; American College of Cardiology
- CMID: Clinical Monitoring Intelligence Database, hypertension, hyperlipidemia and stroke/TIA monographs (2026), Aether Forge
- 2024 Guideline for the Primary Prevention of Stroke: A Guideline From the American Heart Association/American Stroke Association (Bushnell C, et al. Stroke 2024;55:e344-e424) (2024), American Heart Association/American Stroke Association
- 2018 AHA/ACC Guideline on the Management of Blood Cholesterol (Grundy SM, et al. Circulation 2019;139:e1082-e1143) (2018), American Heart Association; American College of Cardiology
- 2020 American College of Rheumatology Guideline for the Management of Gout (FitzGerald JD, et al. Arthritis Care Res 2020;72(6):744-760) (2020), American College of Rheumatology

## Follow-up

- Potassium and creatinine in one to two weeks. Review in four weeks. **S**
- Next scheduled visit 1930-10-27: sixteen-week review: blood pressure, potassium and kidney function on losartan, mood, social needs and stroke prevention. **S**
